⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3659904 | 0.93 | MEN1 (0.38) | — | |
| Fluoride SCHEMBL29252750 | 0.91 | MEN1 (0.37) | — | |
| SCHEMBL8015557 | 0.91 | CYP2D6 (0.41) | — | |
| SCHEMBL11355992 | 0.84 | MEN1 (0.39) | — | |
| SCHEMBL1760704 | 0.79 | — | — | |
| SCHEMBL6188279 | 0.79 | — | — | |
| SCHEMBL1357490 | 0.75 | — | — | |
| SCHEMBL6760550 | 0.72 | — | — | |
| SCHEMBL8412913 | 0.71 | NOS3 (0.39) | — | |
| SCHEMBL16160871 | 0.71 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5686616-A | Process for preparing an optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-11-11 | — | — | US | claimed |
| CN-118369431-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-118355122-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118355123-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118339295-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-111356443-B | Systems, devices, and methods for delivering therapeutic substances to the nasal cavity | 塔斯克医药股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117279653-A | Compounds for the treatment of ocular diseases and disorders | 以色列国家农业和农村发展农业研究组织沃尔坎尼中心 | 2023-12-22 | — | — | CN | disclosed |
| CN-116600803-A | Macrocyclic urea orexin receptor agonists | 默沙东有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| US-20140127762-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALPHA-SUBSTITUTED PROLINE | API CORPORATION (JP) | 2014-05-08 | — | — | US | disclosed |
| CN-103596924-A | Process for producing optically active alpha-substituted proline | API CORP | 2014-02-19 | — | — | CN | disclosed |
| US-5686616-A | Process for preparing an optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-11-11 | — | — | US | disclosed |